Research on genetic variant characteristics in ADME genes based on whole-exome sequencing in the Han Chinese population
We integrated 604 ADME genes and 972 drugs. There were 33,925 single nucleotide polymorphisms (SNPs) and 484 insertion-deletions (InDels) in 5,357 Han Chinese WES samples; 88.9 % were rare. Of the SNPs, 60.9 % are new functional mutations in enzyme and transporter genes; InDels also affected these genes. We discovered Chinese-specific variants in key ADME genes and ethnic-specific metabolic phenotypes that could affect drug use. Finally, we screened 3,657 potentially harmful mutations; 45.6 % are novel. Western blotting and enzyme activity assays confirmed several harmful mutations significantly reduced CYP2C19 gene expression and function (P < 0.01).
Authors
- Chengxian Guo (ORCID: https://orcid.org/0000-0002-6332-6716)
- Hui Qiu
- Jiankui Zhou (ORCID: https://orcid.org/0000-0002-7099-4528)
- Tong Li (ORCID: https://orcid.org/0000-0002-3257-213X)
- Ling Ye
- Xin Huang (ORCID: https://orcid.org/0000-0002-2960-8349)
- Yan Zhan
- Xiangguang Meng (ORCID: https://orcid.org/0009-0007-7725-2619)
Institutions
- Central South University (CN)
- PharmacoGenetics (China) (CN)
- Zhengzhou People's Hospital (CN)
- Third Xiangya Hospital (CN)
Publication Details
- Journal
- European Journal of Pharmaceutical Sciences
- Published
- 2024-12-11
- DOI
- https://doi.org/10.1016/j.ejps.2024.106987
- Citations
- 3
- Primary Topic
- Pharmacogenetics and Drug Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 1.40